Patient and multidisciplinary team perspectives on watch and wait in rectal cancer

被引:3
作者
Mohan, Helen [1 ,2 ,3 ,8 ]
Rabie, Mohammed [2 ]
Walsh, Ciaran [4 ]
Harji, Deena [2 ]
Sutton, Paul [5 ]
Geh, Ian [4 ]
Jackson, Ian [6 ]
Helbren, Emma [7 ]
Evans, Martyn [4 ]
Jenkins, John T. [1 ,4 ]
机构
[1] ACPGBI Adv Malignancy Subcomm, London, England
[2] Dukes Club, London, England
[3] Univ Melbourne, Dept Surg, Melbourne, Australia
[4] ACPGBI Multidisciplinary Clin Comm, London, England
[5] Early Years Consultant Network, London, England
[6] ACPGBI Patient Liaison Grp, London, England
[7] British Soc Gastrointestinal Abdominal Radiol BSGA, London, England
[8] Peter MacCallum Canc Ctr, ACPGBI Adv Malignancy Subcomm, 305 Grattan St, Melbourne, Vic, Australia
关键词
complete response; organ preservation; rectal cancer; watch and wait; CLINICAL COMPLETE RESPONSE; X-RAY BRACHYTHERAPY; LONG-TERM OUTCOMES; NEOADJUVANT CHEMORADIOTHERAPY; PREOPERATIVE CHEMORADIOTHERAPY; NONOPERATIVE TREATMENT; INTERNATIONAL WATCH; ORGAN PRESERVATION; OPEN-LABEL; CHEMORADIATION;
D O I
10.1111/codi.16592
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This article adopts a multidisciplinary approach, including surgery, oncology, radiology and patient perspectives, to discuss the key points of debate surrounding a watch and wait approach. In an era of shared decision-making, discussion of watch and wait as an option in the context of complete clinical response is appropriate, although it is not the gold standard treatment. Key challenges are the difficulty in assessing for a complete clinical response, prediction of recurrence and access to timely diagnostics for surveillance. Salvage surgery has good results if regrowth is detected early but does have imperfect outcomes, with only a 90% salvage rate. Good communication with patients about the risks and alternatives is essential. Patients undergoing watch and wait should ideally be enrolled in prospective registries or clinical trials.
引用
收藏
页码:1489 / 1497
页数:9
相关论文
共 59 条
  • [21] Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study
    Fernandez, Laura M.
    Sao Juliao, Guilherme P.
    Figueiredo, Nuno L.
    Beets, Geerard L.
    van der Valk, Maxime J. M.
    Bahadoer, Renu R.
    Hilling, Denise E.
    Kranenbarg, Elma Meershoek-Klein
    Roodvoets, Annet G. H.
    Renehan, Andrew G.
    van de Velde, Cornelis J. H.
    Habr-Gama, Angelita
    Perez, Rodrigo O.
    [J]. LANCET ONCOLOGY, 2021, 22 (01) : 43 - 50
  • [22] Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients
    Frin, Anne Claire
    Evesque, Ludovic
    Gal, Jocelyn
    Benezery, Karene
    Francois, Eric
    Gugenheim, Jean
    Benizri, Emmanuel
    Chateau, Yan
    Marcie, Serge
    Doyen, Jerome
    Gerard, Jean-Pierre
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 72 : 124 - 136
  • [23] Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy
    Garcia-Aguilar, Julio
    Patil, Sujata
    Gollub, Marc J.
    Kim, Jin K.
    Yuval, Jonathan B.
    Thompson, Hannah M.
    Verheij, Floris S.
    Omer, Dana M.
    Lee, Meghan
    Dunne, Richard F.
    Marcet, Jorge
    Cataldo, Peter
    Polite, Blase
    Herzig, Daniel O.
    Liska, David
    Oommen, Samuel
    Friel, Charles M.
    Ternent, Charles
    Coveler, Andrew L.
    Hunt, Steven
    Gregory, Anita
    Varma, Madhulika G.
    Bello, Brian L.
    Carmichael, Joseph C.
    Krauss, John
    Gleisner, Ana
    Paty, Philip B.
    Weiser, Martin R.
    Nash, Garrett M.
    Pappou, Emmanouil
    Guillem, Jose G.
    Temple, Larissa
    Wei, Iris H.
    Widmar, Maria
    Lin, Sabrina
    Segal, Neil H.
    Cercek, Andrea
    Yaeger, Rona
    Smith, J. Joshua
    Goodman, Karyn A.
    Wu, Abraham J.
    Saltz, Leonard B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) : 2546 - +
  • [24] Optimal Timing of Surgery After Chemoradiation for Advanced Rectal Cancer: Preliminary Results of a Multicenter, Nonrandomized Phase II Prospective Trial
    Garcia-Aguilar, Julio
    Smith, David D.
    Avila, Karin
    Bergsland, Emily K.
    Chu, Peiguo
    Krieg, Richard M.
    [J]. ANNALS OF SURGERY, 2011, 254 (01) : 97 - 102
  • [25] Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3 randomised controlled trial
    Gerard, Jean-Pierre
    Barbet, Nicolas
    Schiappa, Renaud
    Magne, Nicolas
    Martel, Isabelle
    Mineur, Laurent
    Deberne, Melanie
    Zilli, Thomas
    Dhadda, Amandeep
    Myint, Arthur Sun
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (04): : 356 - 367
  • [26] Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial
    Gerard, Jean-Pierre
    Chamorey, Emmanuel
    Gourgou-Bourgade, Sophie
    Benezery, Karene
    de Laroche, Guy
    Mahe, Marc-Andre
    Boige, Valerie
    Juzyna, Beata
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 (02) : 246 - 252
  • [27] The evaluation of follow-up strategies of watch-and-wait patients with a complete response after neoadjuvant therapy in rectal cancer
    Haak, Hester E.
    Zmuc, Jan
    Lambregts, Doenja M. J.
    Beets-Tan, Regina G. H.
    Melenhorst, Jarno
    Beets, Geerard L.
    Maas, Monique
    [J]. COLORECTAL DISEASE, 2021, 23 (07) : 1785 - 1792
  • [28] Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy - Long-term results
    Habr-Gama, A
    Perez, RO
    Nadalin, W
    Sabbaga, J
    Ribeiro, U
    Sousa, AHSE
    Campos, FG
    Kiss, DR
    Gama-Rodrigues, J
    [J]. ANNALS OF SURGERY, 2004, 240 (04) : 711 - 717
  • [29] Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy
    Habr-Gama, Angelita
    Perez, Rodrigo O.
    Proscurshim, Igor
    Campos, Fabio G.
    Nadalin, Wladimir
    Kiss, Desiderio
    Gama-Rodrigues, Joaquim
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2006, 10 (10) : 1319 - 1328
  • [30] Achieving a Complete Clinical Response After Neoadjuvant Chemoradiation That Does Not Require Surgical Resection: It May Take Longer Than You Think!
    Habr-Gama, Angelita
    Sao Juliao, Guilherme P.
    Fernandez, Laura M.
    Vailati, Bruna B.
    Andrade, Andres
    Araujo, Sergio E. A.
    Gama-Rodrigues, Joaquim
    Perez, Rodrigo O.
    [J]. DISEASES OF THE COLON & RECTUM, 2019, 62 (07) : 802 - 808